Einträge von Buser, Lorenz auf dem Publikationsserver

Meyer, Stefanie, Buser, Lorenz , Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas und Garbe, Claus (2023) Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma. European Journal of Cancer 182, S. 77-86. Volltext nicht vorhanden.

Hutterer, Georg C., Posch, Florian, Buser, Lorenz , Zigeuner, Richard, Morshäuser, Laura, Otto, Wolfgang, Wild, Peter J., Burger, Maximilian, May, Matthias, Pichler, Martin und Brookman-May, Sabine D. (2019) BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study. Urologic Oncology: Seminars and Original Investigations 37 (7), S. 510-518. Volltext nicht vorhanden.

Morshaeuser, Laura, May, Matthias, Burger, Maximilian, Otto, Wolfgang, Hutterer, Georg C., Pichler, Martin, Klatte, Tobias, Wild, Peter, Buser, Lorenz und Brookman-May, Sabine (2018) p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urologic Oncology: Seminars and Original Investigations 36 (3), 94.e15-94.e21. Volltext nicht vorhanden.